Does NIVOLUMAB Cause Myocarditis? 959 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 959 reports of Myocarditis have been filed in association with NIVOLUMAB (OPDIVO). This represents 1.1% of all adverse event reports for NIVOLUMAB.
959
Reports of Myocarditis with NIVOLUMAB
1.1%
of all NIVOLUMAB reports
369
Deaths
614
Hospitalizations
How Dangerous Is Myocarditis From NIVOLUMAB?
Of the 959 reports, 369 (38.5%) resulted in death, 614 (64.0%) required hospitalization, and 307 (32.0%) were considered life-threatening.
Is Myocarditis Listed in the Official Label?
Yes, Myocarditis is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Myocarditis?
CLOZAPINE (1,702)
PEMBROLIZUMAB (1,060)
IPILIMUMAB (475)
OLANZAPINE (425)
ATEZOLIZUMAB (372)
CARBOPLATIN (325)
QUETIAPINE (315)
MESALAMINE (272)
BEVACIZUMAB (230)
PACLITAXEL (225)
Which NIVOLUMAB Alternatives Have Lower Myocarditis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE